Trademark: 85254599
Word
CGSTAR
Status
Dead
Status Code
710
Status Date
Friday, April 13, 2018
Serial Number
85254599
Registration Number
4022848
Registration Date
Tuesday, September 6, 2011
Mark Type
4000
Filing Date
Tuesday, March 1, 2011
Published for Opposition
Tuesday, June 21, 2011
Cancellation Date
Friday, April 13, 2018

Trademark Owner History
SANOFI - Original Registrant
sanofi-aventis - Owner At Publication

Classifications
9 Software intended for diabetic patients for recording blood test results from a blood glucose monitor
10 Medical monitors for detecting, measuring and monitoring blood glucose levels and parts thereof

Trademark Events
Apr 13, 2018
Cancelled Sec. 8 (6-Yr)
Apr 5, 2017
Review Of Correspondence Complete - Address Updated
Jan 31, 2017
Correspondence Received In Law Office
Mar 7, 2012
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 7, 2012
Teas Change Of Owner Address Received
Sep 6, 2011
Registered-Principal Register
Jun 29, 2011
Changes/Corrections After Pub Approval Entered
Jun 23, 2011
Assigned To Petition Staff
Jun 22, 2011
Teas Post Publication Amendment Received
Jun 21, 2011
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2011
Published For Opposition
Jun 1, 2011
Assignment Of Ownership Not Updated Automatically
May 16, 2011
Law Office Publication Review Completed
May 12, 2011
Assigned To Lie
May 12, 2011
Approved For Pub - Principal Register
May 9, 2011
Examiner's Amendment Entered
May 9, 2011
Notification Of Examiners Amendment E-Mailed
May 9, 2011
Examiners Amendment E-Mailed
May 9, 2011
Examiners Amendment -Written
May 5, 2011
Teas/Email Correspondence Entered
May 4, 2011
Correspondence Received In Law Office
May 4, 2011
Teas Response To Suspension Inquiry Received
Apr 15, 2011
Notification Of Letter Of Suspension E-Mailed
Apr 15, 2011
Letter Of Suspension E-Mailed
Apr 15, 2011
Suspension Letter Written
Apr 10, 2011
Assigned To Examiner
Mar 4, 2011
New Application Office Supplied Data Entered In Tram
Mar 4, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24